Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology
Fibromyalgia syndrome (FMS) is a chronic condition with unknown aetiology. The pathophysiology of the disease is incompletely understood; despite advances in our knowledge with regards to abnormal central and peripheral pain processing, and hypothalamo–pituitary–adrenal dysfunction, there is no clea...
Main Authors: | Sanam Kia, Ernet Choy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/5/2/20 |
Similar Items
-
Chronic pain syndrome—Fibromyalgia
by: Da-Ming Liao, et al.
Published: (2023-01-01) -
A comparison of patients diagnosed with fibromyalgia syndrome and patients diagnosed without fibromyalgia syndrome in terms of early maladaptive schemas
by: Özgür Erdem Arıcı, et al.
Published: (2021-08-01) -
Update on fibromyalgia
by: Fabiola Atzeni, et al.
Published: (2012-01-01) -
Non-pharmacological Therapy in Fibromyalgia
by: Martyna Rozenbajgier, et al.
Published: (2022-09-01) -
Consensus evidence-based clinical practice recommendations for the management of fibromyalgia
by: Yasser El Miedany, et al.
Published: (2022-05-01)